search
Back to results

Mobile Integrated Health in Heart Failure

Primary Purpose

Heart Failure

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mobile Integrated Health (MIH)
Transitions of care coordinator (TOCC)
Sponsored by
Weill Medical College of Cornell University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Medicare or Medicaid recipient
  • Current diagnosis of HF
  • Receiving inpatient care at NewYork Presbyterian or Mount Sinai Health Systems
  • Live in NYC, specifically Manhattan, Brooklyn, Queens or the Bronx

Exclusion Criteria:

  • Non-English, Spanish, Mandarin, or French speaking
  • Diagnosis of dementia or psychosis
  • Anticipated discharge to, or current residence in, skilled nursing facility or rehab center
  • Anticipated discharge to, or currently receiving, hospice including home hospice
  • Current candidate for and awaiting heart transplant
  • Current left ventricular assist device (LVAD)

Sites / Locations

  • Mount Sinai Health SystemRecruiting
  • New York Presbyterian/Weill Cornell MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Mobile Integrated Health (MIH)

Transitions of care coordinator (TOCC)

Arm Description

Patients with urgent medical needs are seen and treated in the home by trained community paramedics. The community paramedics perform a standardized assessment, including a physical examination, vital signs, home safety evaluation, and medication reconciliation. During the MIH encounter, the emergency medicine physician at each site is contacted via telemedicine. Physicians can access clinical notes, discharge summaries, and medication lists via the institutional EHR. Adjustments to outpatient medications can be e-prescribed and follow-up appointments can be scheduled with primary care clinicians.

Patients receive a follow-up phone calls for a nurse coordinator within 48-72 hours of hospital discharge. Phone calls include clinical/social needs assessment with escalation to primary care team, emergency care, or social work as needed; patient education; and reminder about follow-up appointments.

Outcomes

Primary Outcome Measures

Number of all-cause hospital readmissions
Number of readmissions to the hospital for any reason following a hospitalization
Patient-reported health-related quality of life score assessed using the KCCQ
Patient-reported health-related quality of life score assessed using the Kansas City Cardiomyopathy Questionnaire 23-item scale (KCCQ-23). KCCQ-23 scores range from 0 to 100, with lower scores (closer to 0) indicating worse symptoms and physical functioning, and higher scores (closer to 100) indicating better symptoms and physical functioning.

Secondary Outcome Measures

Number of preventable emergency department visits
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Number of preventable emergency department visits
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Number of preventable emergency department visits
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Number of preventable emergency department visits
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Number of unplanned hospital readmissions
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Number of unplanned hospital readmissions
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Number of unplanned hospital readmissions
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Number of unplanned hospital readmissions
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Number of days at home
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Number of days at home
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Number of days at home
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Number of days at home
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Patient-reported symptoms and functioning score assessed using PROMIS-29
Patient-reported symptoms and functioning score, measured using the Patient-Reported Outcomes Measurement Information System 29-item survey (PROMIS-29). PROMIS-29 domains are scored separately: physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, and pain interference. Each domain is scored using a standardized T-score ranging from approximately 20 to 80, with lower scores indicating less of the symptom (i.e., less fatigue), and higher scores indicating more of the symptom (i.e., more fatigue).
Patient-reported symptoms and functioning score assessed using PROMIS-29
Patient-reported symptoms and functioning score, measured using the Patient-Reported Outcomes Measurement Information System 29-item survey (PROMIS-29). PROMIS-29 domains are scored separately: physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, and pain interference. Each domain is scored using a standardized T-score ranging from approximately 20 to 80, with lower scores indicating less of the symptom (i.e., less fatigue), and higher scores indicating more of the symptom (i.e., more fatigue).
Patient-reported symptoms and functioning score assessed using PROMIS-29
Patient-reported symptoms and functioning score, measured using the Patient-Reported Outcomes Measurement Information System 29-item survey (PROMIS-29). PROMIS-29 domains are scored separately: physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, and pain interference. Each domain is scored using a standardized T-score ranging from approximately 20 to 80, with lower scores indicating less of the symptom (i.e., less fatigue), and higher scores indicating more of the symptom (i.e., more fatigue).
Patient self-care score assessed using the SCHFI
Patient self-care score assessed using the Self-Care of Heart Failure Index (SCHFI). SCHFI standardized scores are reported separately for each domain: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with lower scores (closer to 0) representing worse self-care and higher scores (closer to 100) representing better self-care.
Patient self-care score assessed using the SCHFI
Patient self-care score assessed using the Self-Care of Heart Failure Index (SCHFI). SCHFI standardized scores are reported separately for each domain: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with lower scores (closer to 0) representing worse self-care and higher scores (closer to 100) representing better self-care.
Patient self-care score assessed using the SCHFI
Patient self-care score assessed using the Self-Care of Heart Failure Index (SCHFI). SCHFI standardized scores are reported separately for each domain: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with lower scores (closer to 0) representing worse self-care and higher scores (closer to 100) representing better self-care.
Patient-reported health-related quality of life score assessed using the KCCQ
Patient-reported health-related quality of life score assessed using the Kansas City Cardiomyopathy Questionnaire 23-item scale (KCCQ-23). KCCQ-23 scores range from 0 to 100, with lower scores (closer to 0) indicating worse symptoms and physical functioning, and higher scores (closer to 100) indicating better symptoms and physical functioning.
Patient-reported health-related quality of life score assessed using the KCCQ
Patient-reported health-related quality of life score assessed using the Kansas City Cardiomyopathy Questionnaire 23-item scale (KCCQ-23). KCCQ-23 scores range from 0 to 100, with lower scores (closer to 0) indicating worse symptoms and physical functioning, and higher scores (closer to 100) indicating better symptoms and physical functioning.
Number of all-cause hospital readmissions
Number of readmissions to the hospital for any reason following a hospitalization
Number of all-cause hospital readmissions
Number of readmissions to the hospital for any reason following a hospitalization
Number of all-cause hospital readmissions
Number of readmissions to the hospital for any reason following a hospitalization
National Quality Forum metric: Follow-up appointment attendance
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
National Quality Forum metric: Follow-up appointment attendance
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
National Quality Forum metric: Follow-up appointment attendance
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
National Quality Forum metric: Follow-up appointment attendance
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
National Quality Forum metric: Prescription medications
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
National Quality Forum metric: Prescription medications
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
National Quality Forum metric: Prescription medications
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
National Quality Forum metric: Prescription medications
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
National Quality Forum metric: Functional status assessment
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
National Quality Forum metric: Functional status assessment
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
National Quality Forum metric: Functional status assessment
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
National Quality Forum metric: Functional status assessment
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.

Full Information

First Posted
December 4, 2020
Last Updated
May 25, 2022
Sponsor
Weill Medical College of Cornell University
Collaborators
Patient-Centered Outcomes Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT04662541
Brief Title
Mobile Integrated Health in Heart Failure
Official Title
Using Mobile Integrated Health and Telehealth to Support Transitions of Care Among Heart Failure Patients - Parent Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
April 30, 2023 (Anticipated)
Study Completion Date
April 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University
Collaborators
Patient-Centered Outcomes Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to compare how two different types of care after a hospitalization reduce hospital readmissions and symptom burden. The two types of care are a Transitions of Care Coordinator and Mobile Integrated Health. In the Transitions of Care Coordinator group, participants will receive a phone call from a care coordinator right after they go home following a hospitalization to check in. In the Mobile Integrated Health group, participants will be offered access to a community paramedic in case they need medical care while they are recovering at home after a hospitalization. The community paramedic will come to their home to perform an evaluation and set up a visit with an emergency physician via video conference. They may receive treatment at home or be transported to the emergency department. The investigators will be compare how well a Transitions of Care Coordinator and Mobile Integrated Health reduce readmissions to the hospital within 30 days of discharge and improve patient-reported health-related quality of life. The investigators hypothesize that participants in the Mobile Integrated Health group will have fewer readmissions to the hospital within 30 days of discharge and better health-related quality of life compared to participants in the Transitions of Care Coordinator group.
Detailed Description
High 30-day readmission rates among heart failure (HF) patients (25% nationally) inflict substantial burden on both health systems and patients. The majority of hospital readmissions occur in the first seven days following a hospitalization for HF and are driven by lack of improvement in persistent symptoms. While early, proactive follow-up after hospital discharge can improve health outcomes and patient-reported quality of life, barriers within health systems (lack of appointment availability, transportation, limited ability to deliver medical therapies in the home) have hampered efforts to provide comprehensive follow-up. Evidence suggests that Mobile Integrated Health (MIH), involving community paramedicine coupled with telemedicine, may be an effective intervention to reduce readmissions. The long-term goal of this research is to provide rigorous evidence of MIH with a diverse, representative sample. In this pragmatic randomized clinical trial the investigators will compare MIH to a Transitions of Care Coordinator (TOCC) intervention. Specifically, the investigators aim to compare the effectiveness of MIH versus TOCC on healthcare utilization (aim 1), patient-reported outcomes (PROs; aim 2), and healthcare quality (aim 3). The investigators will also evaluate the factors that support the adoption, implementation, and maintenance from the perspective of multiple key stakeholders (aim 4). Participants in this RCT will be randomized 1:1 to either MIH (intervention) or TOCC (comparator). All participants will be enrolled and randomized during a hospitalization for HF. Participants in MIH will receive a follow-up phone call and access to community paramedics who provide a comprehensive assessment in the home, and specific medical therapies while consulting with an emergency room physician in real-time via telemedicine. Participants in TOCC will receive a follow-up phone call within 48-72 hours of discharge and connection to appropriate services (social work, care coordination, home care) as needed. Participants in both groups will complete PROs using a rigorously developed, visually enhanced mobile PRO reporting system. The study population will include patients at NewYork-Presbyterian (NYP) and Mount Sinai health systems, which are part of the New York City-based INSIGHT PCORI-funded clinical research network. The targeted sample size across the two sites is 2,100 patients (1,050 per arm). This record is for the parent PCORI-funded trial evaluating MIH among HF patients. There is a separate sub-study being conducted locally at NYP which is described in another record.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mobile Integrated Health (MIH)
Arm Type
Experimental
Arm Description
Patients with urgent medical needs are seen and treated in the home by trained community paramedics. The community paramedics perform a standardized assessment, including a physical examination, vital signs, home safety evaluation, and medication reconciliation. During the MIH encounter, the emergency medicine physician at each site is contacted via telemedicine. Physicians can access clinical notes, discharge summaries, and medication lists via the institutional EHR. Adjustments to outpatient medications can be e-prescribed and follow-up appointments can be scheduled with primary care clinicians.
Arm Title
Transitions of care coordinator (TOCC)
Arm Type
Active Comparator
Arm Description
Patients receive a follow-up phone calls for a nurse coordinator within 48-72 hours of hospital discharge. Phone calls include clinical/social needs assessment with escalation to primary care team, emergency care, or social work as needed; patient education; and reminder about follow-up appointments.
Intervention Type
Other
Intervention Name(s)
Mobile Integrated Health (MIH)
Intervention Description
MIH leverages paramedics in the community and telemedicine (technology-enabled communication for health purposes) to provide medical care to heart failure patients in the home.
Intervention Type
Other
Intervention Name(s)
Transitions of care coordinator (TOCC)
Intervention Description
The TOCC group will receive a follow-up phone call shortly after discharge in which the patient is assessed and connected to clinical and social services as needed and patient education is reinforced.
Primary Outcome Measure Information:
Title
Number of all-cause hospital readmissions
Description
Number of readmissions to the hospital for any reason following a hospitalization
Time Frame
30 days
Title
Patient-reported health-related quality of life score assessed using the KCCQ
Description
Patient-reported health-related quality of life score assessed using the Kansas City Cardiomyopathy Questionnaire 23-item scale (KCCQ-23). KCCQ-23 scores range from 0 to 100, with lower scores (closer to 0) indicating worse symptoms and physical functioning, and higher scores (closer to 100) indicating better symptoms and physical functioning.
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Number of preventable emergency department visits
Description
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Time Frame
30 days
Title
Number of preventable emergency department visits
Description
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Time Frame
60 days
Title
Number of preventable emergency department visits
Description
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Time Frame
90 days
Title
Number of preventable emergency department visits
Description
Number of emergency department visits following a hospitalization that are considered preventable according to a previously validated algorithm
Time Frame
6 months
Title
Number of unplanned hospital readmissions
Description
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Time Frame
30 days
Title
Number of unplanned hospital readmissions
Description
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Time Frame
60 days
Title
Number of unplanned hospital readmissions
Description
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Time Frame
90 days
Title
Number of unplanned hospital readmissions
Description
Number of readmissions to the hospital following a hospitalization that are considered unplanned according to a validated algorithm
Time Frame
6 months
Title
Number of days at home
Description
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Time Frame
30 days
Title
Number of days at home
Description
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Time Frame
60 days
Title
Number of days at home
Description
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Time Frame
90 days
Title
Number of days at home
Description
Number of days at home (alive and not in a hospital or other medical facility) following a hospitalization
Time Frame
6 months
Title
Patient-reported symptoms and functioning score assessed using PROMIS-29
Description
Patient-reported symptoms and functioning score, measured using the Patient-Reported Outcomes Measurement Information System 29-item survey (PROMIS-29). PROMIS-29 domains are scored separately: physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, and pain interference. Each domain is scored using a standardized T-score ranging from approximately 20 to 80, with lower scores indicating less of the symptom (i.e., less fatigue), and higher scores indicating more of the symptom (i.e., more fatigue).
Time Frame
30 days
Title
Patient-reported symptoms and functioning score assessed using PROMIS-29
Description
Patient-reported symptoms and functioning score, measured using the Patient-Reported Outcomes Measurement Information System 29-item survey (PROMIS-29). PROMIS-29 domains are scored separately: physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, and pain interference. Each domain is scored using a standardized T-score ranging from approximately 20 to 80, with lower scores indicating less of the symptom (i.e., less fatigue), and higher scores indicating more of the symptom (i.e., more fatigue).
Time Frame
60 days
Title
Patient-reported symptoms and functioning score assessed using PROMIS-29
Description
Patient-reported symptoms and functioning score, measured using the Patient-Reported Outcomes Measurement Information System 29-item survey (PROMIS-29). PROMIS-29 domains are scored separately: physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, and pain interference. Each domain is scored using a standardized T-score ranging from approximately 20 to 80, with lower scores indicating less of the symptom (i.e., less fatigue), and higher scores indicating more of the symptom (i.e., more fatigue).
Time Frame
90 days
Title
Patient self-care score assessed using the SCHFI
Description
Patient self-care score assessed using the Self-Care of Heart Failure Index (SCHFI). SCHFI standardized scores are reported separately for each domain: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with lower scores (closer to 0) representing worse self-care and higher scores (closer to 100) representing better self-care.
Time Frame
30 days
Title
Patient self-care score assessed using the SCHFI
Description
Patient self-care score assessed using the Self-Care of Heart Failure Index (SCHFI). SCHFI standardized scores are reported separately for each domain: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with lower scores (closer to 0) representing worse self-care and higher scores (closer to 100) representing better self-care.
Time Frame
60 days
Title
Patient self-care score assessed using the SCHFI
Description
Patient self-care score assessed using the Self-Care of Heart Failure Index (SCHFI). SCHFI standardized scores are reported separately for each domain: self-care maintenance, self-care monitoring, and self-care management. Scores range from 0 to 100, with lower scores (closer to 0) representing worse self-care and higher scores (closer to 100) representing better self-care.
Time Frame
90 days
Title
Patient-reported health-related quality of life score assessed using the KCCQ
Description
Patient-reported health-related quality of life score assessed using the Kansas City Cardiomyopathy Questionnaire 23-item scale (KCCQ-23). KCCQ-23 scores range from 0 to 100, with lower scores (closer to 0) indicating worse symptoms and physical functioning, and higher scores (closer to 100) indicating better symptoms and physical functioning.
Time Frame
60 days
Title
Patient-reported health-related quality of life score assessed using the KCCQ
Description
Patient-reported health-related quality of life score assessed using the Kansas City Cardiomyopathy Questionnaire 23-item scale (KCCQ-23). KCCQ-23 scores range from 0 to 100, with lower scores (closer to 0) indicating worse symptoms and physical functioning, and higher scores (closer to 100) indicating better symptoms and physical functioning.
Time Frame
90 days
Title
Number of all-cause hospital readmissions
Description
Number of readmissions to the hospital for any reason following a hospitalization
Time Frame
60 days
Title
Number of all-cause hospital readmissions
Description
Number of readmissions to the hospital for any reason following a hospitalization
Time Frame
90 days
Title
Number of all-cause hospital readmissions
Description
Number of readmissions to the hospital for any reason following a hospitalization
Time Frame
6 months
Title
National Quality Forum metric: Follow-up appointment attendance
Description
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
Time Frame
30 days
Title
National Quality Forum metric: Follow-up appointment attendance
Description
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
Time Frame
60 days
Title
National Quality Forum metric: Follow-up appointment attendance
Description
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
Time Frame
90 days
Title
National Quality Forum metric: Follow-up appointment attendance
Description
Binary indicator of whether the patient attended a follow-up appointment after discharge among those with a scheduled follow-up appointment at discharge.
Time Frame
6 months
Title
National Quality Forum metric: Prescription medications
Description
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
Time Frame
30 days
Title
National Quality Forum metric: Prescription medications
Description
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
Time Frame
60 days
Title
National Quality Forum metric: Prescription medications
Description
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
Time Frame
90 days
Title
National Quality Forum metric: Prescription medications
Description
Binary indicator of whether the patient was prescribed either an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker therapy plus a Beta-Blocker Therapy as clinically indicated on discharge.
Time Frame
6 months
Title
National Quality Forum metric: Functional status assessment
Description
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
Time Frame
30 days
Title
National Quality Forum metric: Functional status assessment
Description
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
Time Frame
60 days
Title
National Quality Forum metric: Functional status assessment
Description
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
Time Frame
90 days
Title
National Quality Forum metric: Functional status assessment
Description
Binary indicator of whether the patient had a functional status assessment completed in their chart after hospital discharge.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Medicare or Medicaid recipient Current diagnosis of HF Receiving inpatient care at NewYork Presbyterian or Mount Sinai Health Systems Live in NYC, specifically Manhattan, Brooklyn, Queens or the Bronx Exclusion Criteria: Non-English, Spanish, Mandarin, or French speaking Diagnosis of dementia or psychosis Anticipated discharge to, or current residence in, skilled nursing facility or rehab center Anticipated discharge to, or currently receiving, hospice including home hospice Current candidate for and awaiting heart transplant Current left ventricular assist device (LVAD)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ruth M Masterson Creber, PhD, MSc, RN
Phone
646-962-2435
Email
rmc2009@med.cornell.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Rainu Kaushal, MD, MPH
Phone
646-962-8006
Email
rak2007@med.cornell.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruth M Masterson Creber, PhD, MSc, RN
Organizational Affiliation
Weill Medical College of Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mount Sinai Health System
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Roland Merchant, MD, MPH, ScD
Phone
212-824-9814
Email
Roland.Merchant@mountsinai.org
First Name & Middle Initial & Last Name & Degree
Roland Merchant, MD, MPH, ScD
Facility Name
New York Presbyterian/Weill Cornell Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brock Daniels, MD, MPH
Phone
212-746-0780
Email
brd9088@med.cornell.edu
First Name & Middle Initial & Last Name & Degree
Brock Daniels, MD, MPH

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35273051
Citation
Masterson Creber RM, Daniels B, Munjal K, Reading Turchioe M, Shafran Topaz L, Goytia C, Diaz I, Goyal P, Weiner M, Yu J, Khullar D, Slotwiner D, Ramasubbu K, Kaushal R. Using Mobile Integrated Health and telehealth to support transitions of care among patients with heart failure (MIGHTy-Heart): protocol for a pragmatic randomised controlled trial. BMJ Open. 2022 Mar 10;12(3):e054956. doi: 10.1136/bmjopen-2021-054956.
Results Reference
derived

Learn more about this trial

Mobile Integrated Health in Heart Failure

We'll reach out to this number within 24 hrs